Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | SCN4A | P35499 | 1/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.38 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.38 |
| ▸ | P2RX4 | Q99571 | 11/20 | 0.38 |
| ▸ | P2RX1 | P51575 | 6/20 | 0.38 |
| ▸ | P2RX3 | P56373 | 6/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | IDH1 | O75874 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31558693 | 1.00 | MEN1 (0.40) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL3253414 | 0.78 | MEN1 (0.42) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL28017429 | 0.78 | MEN1 (0.39) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL28016737 | 0.78 | KMT2A (0.39) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL27594996 | 0.75 | SMN1; SMN2 (0.49) | MEN1KMT2ALMNASMN1; SMN2MAPK1 | |
| SCHEMBL5527248 | 0.73 | ALDH1A1 (0.42) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL28886571 | 0.73 | SMN1; SMN2 (0.42) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL935561 | 0.73 | LMNA (0.37) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL11792980 | 0.73 | SMN1; SMN2 (0.46) | MEN1KMT2ALMNASMN1; SMN2TSHR | |
| SCHEMBL11197612 | 0.73 | MEN1 (0.54) | MEN1KMT2ALMNASMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109563432-A | Grease composition | 协同油脂株式会社 | 2019-04-02 | — | — | CN | claimed |
| EP-2352876-B1 | TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS | BASF SE (DE) | 2012-12-12 | — | — | EP | claimed |
| US-20110217348-A1 | TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS | BASF SE (DE) | 2011-09-08 | — | — | US | claimed |
| US-20030162809-A1 | Use of dihydroxyquinoline to aid in increasing milk production and feed utilization | SOLUTIA, INC. (US) | 2003-08-28 | — | — | US | claimed |
| EP-0998193-B1 | USE OF DIHYDROXYQUINOLINE COMPOUNDS TO EXTEND THE SHELF LIFE OF PRODUCTS OF MAMMALS AND FISH | SOLUTIA INC (US) | 2003-01-29 | — | — | EP | claimed |
| CN-109563432-A | Grease composition | 协同油脂株式会社 | 2019-04-02 | — | — | CN | disclosed |
| EP-2352876-B1 | TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS | BASF SE (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-20110217348-A1 | TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS | BASF SE (DE) | 2011-09-08 | — | — | US | disclosed |
| CN-100532392-C | Reductive alkylation process | ADVANCED MEDICINE INC (US) | 2009-08-26 | — | — | CN | disclosed |
| CN-100469788-C | Glycopeptide phosphonate derivatives | ADVANCED MEDICINE INC (US) | 2009-03-18 | — | — | CN | disclosed |
| CN-100418980-C | Method for purifying glycopeptide phosphonate derivatives | THERAVANCE INC (US) | 2008-09-17 | — | — | CN | disclosed |
| JP-2008143891-A | NEW 1,2-DIHYDROXYQUINOLINE DERIVATIVE HAVING (SUBSTITUTED PHENYL OR SUBSTITUTED HETEROCYCLIC)CARBONYLOXY LOWER ALKYL GROUP AND ESTER STRUCTURE-INTRODUCED PHENYL GROUP AS SUBSTITUENT | SANTEN PHARMACEUT CO LTD | 2008-06-26 | — | — | JP | disclosed |
| EP-0998193-B1 | USE OF DIHYDROXYQUINOLINE COMPOUNDS TO EXTEND THE SHELF LIFE OF PRODUCTS OF MAMMALS AND FISH | SOLUTIA INC (US) | 2003-01-29 | — | — | EP | disclosed |
| CN-1315961-A | Glycopeptide derivatives and pharmaceutical compositions containing same | ADVANCED MEDICINE INC (US) | 2001-10-03 | — | — | CN | disclosed |
| EP-0998193-A4 | USE OF DIHYDROXYQUINOLINE COMPOUNDS TO EXTEND THE SHELF LIFE OF PRODUCTS OF MAMMALS AND FISH | SOLUTIA INC (US) | 2000-05-31 | — | — | EP | disclosed |
| EP-0998193-A1 | USE OF DIHYDROXYQUINOLINE COMPOUNDS TO EXTEND THE SHELF LIFE OF PRODUCTS OF MAMMALS AND FISH | Solutia Inc. (US) | 2000-05-10 | — | — | EP | disclosed |
| WO-1999016441-A1 | APORPHINOID MATRIX METALLOPROTEINASE INHIBITORS | ROCHE DIAGNOSTICS GMBH (DE) | 1999-04-08 | — | — | WO | disclosed |
| WO-1999004624-A1 | USE OF DIHYDROXYQUINOLINE COMPOUNDS TO EXTEND THE SHELF LIFE OF PRODUCTS OF MAMMALS AND FISH | SOLUTIA INC. (US) | 1999-02-04 | — | — | WO | disclosed |
| EP-0752872-A1 | NADH OXIDASE AS A TARGET IN DIAGNOSIS AND THERAPY | Portola Sciences, Inc. (US) | 1997-01-15 | — | — | EP | disclosed |
| WO-1995026743-A1 | NADH OXIDASE AS A TARGET IN DIAGNOSIS AND THERAPY | PORTOLA SCIENCES, INC. (US) | 1995-10-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162809-A1 | Use of dihydroxyquinoline to aid in increasing milk production and feed utilization | NDUFB5, NQO2, DBH | MEN1 4061/4885KMT2A 939/4885LMNA 3770/4885 |
| US-20110217348-A1 | TREATED TEXTILE MATERIAL FOR USE IN AQUATIC ENVIRONMENTS | C9, ADORA2B, C5 | MEN1 890/4885KMT2A 2066/4885LMNA 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.